These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22933346)

  • 21. Challenges and importance of finding hidden confounders when conducting comparative effectiveness studies using registry data: the impact of surgical turn-down on percutaneous coronary intervention mortality.
    Garratt KN
    Circulation; 2014 Dec; 130(25):2269-71. PubMed ID: 25391520
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic syndrome, CKD progression, and death: the good, the bad, and the ugly.
    Lea JP
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):893-5. PubMed ID: 23685948
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal function and drug-eluting stent.
    Briguori C; Airoldi F; Chieffo A; Carlino M; Montorfano M; Colombo A
    Int J Cardiol; 2010 Jun; 142(1):92-4. PubMed ID: 19147241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.
    Waldo SW; Secemsky EA; O'Brien C; Kennedy KF; Pomerantsev E; Sundt TM; McNulty EJ; Scirica BM; Yeh RW
    Circulation; 2014 Dec; 130(25):2295-301. PubMed ID: 25391519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stents.
    Sardi GL; Loh JP; Torguson R; Laynez-Carnicero A; Kitabata H; Xue Z; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Mar; 15(2):86-91. PubMed ID: 24684759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of worsening renal dysfunction on the comparative efficacy of bivalirudin and platelet glycoprotein IIb/IIIa inhibitors: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Perdoncin E; Zhang M; Riba A; LaLonde TA; Grines CL; Gurm HS
    Circ Cardiovasc Interv; 2013 Dec; 6(6):688-93. PubMed ID: 24280966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.
    Chaikriangkrai K; Nabi F; Mahmarian JJ; Chang SM
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1619-26. PubMed ID: 26243534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of revascularization strategy in patients with acute myocardial infarction and renal insufficiency with multivessel disease.
    Park H; Hong YJ; Rhew SH; Kim SS; Jeong YW; Jeong HC; Cho JY; Jang SY; Lee KH; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC
    Korean J Intern Med; 2015 Mar; 30(2):177-90. PubMed ID: 25750559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary stent thrombosis in patients with chronic kidney disease: balancing anti-ischemic efficacy and hemorrhagic risk.
    Belardi JA; Albertal M
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):368-9. PubMed ID: 22933347
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal outcome of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Nomura S; Taki F; Tamagaki K; Futatsuyama M; Nishihara S; Anzai H; Nishi Y; Takao N; Hayashida N; Komatsu Y
    Int J Cardiol; 2011 Jan; 146(2):295-6. PubMed ID: 21095626
    [No Abstract]   [Full Text] [Related]  

  • 31. An optimal strategy for coronary revascularization in patients with severe renal dysfunction.
    Komiya T; Ueno G; Kadota K; Mitsudo K; Okabayashi H; Nishiwaki N; Hanyu M; Kimura T; Tanaka S; Marui A; Sakata R;
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):293-300. PubMed ID: 25416698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
    Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal strategy of coronary revascularization in chronic kidney disease patients: a meta-analysis.
    Chen YY; Wang JF; Zhang YJ; Xie SL; Nie RQ
    Eur J Intern Med; 2013 Jun; 24(4):354-61. PubMed ID: 23602222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary Artery Bypass Surgery versus Percutaneous Coronary Intervention for Left Main Coronary Artery Disease with Chronic Kidney Disease.
    Lin TC; Lu TM; Huang FC; Hsu PF; Shih CC; Lin SJ; Hsu CP
    Int Heart J; 2018 Mar; 59(2):279-285. PubMed ID: 29563384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Comparison of Xience V and Multi-Link Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease (RENAL-DES) Study.
    Tomai F; Ribichini F; De Luca L; Petrolini A; Ghini AS; Weltert L; Spaccarotella C; Proietti I; Trani C; Nudi F; Pighi M; Vassanelli C
    Circulation; 2014 Mar; 129(10):1104-12. PubMed ID: 24357403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era.
    Nauta ST; van Domburg RT; Nuis RJ; Akkerhuis M; Deckers JW
    Kidney Int; 2013 Aug; 84(2):353-8. PubMed ID: 23486524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current role of coronary artery bypass in diabetics with multivessel coronary disease.
    Grover FL; Mack MJ
    EuroIntervention; 2013 Jun; 9(2):183-6. PubMed ID: 23793006
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.
    Wada H; Ogita M; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Suwa S; Daida H
    Heart Vessels; 2017 Jan; 32(1):16-21. PubMed ID: 27107767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-year clinical outcomes of staged, ad hoc and culprit-only percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease.
    Kim MC; Jeong MH; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Hong YJ; Park HW; Kim JH; Ahn Y; Cho JG; Park JC
    Int J Cardiol; 2014 Sep; 176(2):505-7. PubMed ID: 25049009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.